Short Communication - (2016) Volume 5, Issue 4

The Benefit and Tolerability of Adjuvant Chemotherapy in Elderly Stage III Colon Cancer Patients: A 3 Year Retrospective Audit

Hui-Shan Lin1*, Dylan J Turner2, Archana Srivastava2 and Michael B Jameson2,3
1Centre for Research in Geriatric Medicine, The University of Queensland, Brisbane, Australia, E-mail: dylanj.tuner@rediffmail.com
2Medical Oncology Department, Waikato Hospital, Hamilton, New Zealand, E-mail: dylanj.tuner@rediffmail.com
3Waikato Clinical Campus, Faculty of Medical and Health Sciences, University of Auckland, Hamilton, New Zealand, E-mail: dylanj.tuner@rediffmail.com
*Corresponding Author: